Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Bachem Holding AG is a Swiss company specializing in the biotechnology and pharmaceutical industries. It focuses on the development and production of peptides and oligonucleotides for the pharmaceutical and biotech sectors. Its offerings include active pharmaceutical ingredients (APIs) and customized synthesis services. Founded in 1971, Bachem's headquarters is located in Bubendorf, Switzerland, with additional facilities in the United States, Europe, and Asia. The company is known for its extensive expertise in peptide chemistry and its strategic focus on innovation and quality in manufacturing, contributing to its competitive position in the global pharmaceuticals market.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Bachem Holding AGEli Lilly
Last price
CHF 83.65$1,417.54
Currency
CHF
USD
CHF 6.3B$1.2T
42.5444.58
CHF 1.98$30.81
0.79-
CHF 0.90$6.69
0.53%0.50%
Sector
HealthHealth
Employees
2,72550,000
Ticker
Fr. BANB$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.BANB or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.